NASDAQ:BTCY Biotricity Q4 2025 Earnings Results & Report $0.06 +0.00 (+7.14%) As of 11/10/2026 03:06 PM Eastern Biotricity reported Q4 2025 earnings on July 15, 2025. The company reported EPS of -$0.06, while revenue was $3.70 million. Research:ProfileEarnings History Earnings Announcement Details QuarterQ4 2025Report DateJuly 15, 2025TimeAfter Market ClosesConference Call9:30 AM ET Biotricity EPS ResultsActual EPS-$0.06Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate6 of last 8 quartersBiotricity Revenue ResultsActual Revenue$3.70 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsBiotricity's Q2 2027 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedulesConference Call ResourcesAnnual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(10-K) Biotricity Q4 2025 Earnings FAQ Did Biotricity beat earnings estimates for Q4 2025? Biotricity (NASDAQ:BTCY) reported earnings of -$0.06 per share for Q4 2025. The report was announced on Tuesday, July 15, 2025. What was Biotricity's revenue for Q4 2025? Biotricity reported revenue of $3.70 million for Q4 2025. When is Biotricity's next earnings date? Biotricity's next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Biotricity on the company's earnings history page. Biotricity Earnings HeadlinesBiotricity Q3 2026 Earnings Call: Complete TranscriptFebruary 14, 2026 | benzinga.comBiotricity, Inc. (OTC:BTCY) Q3 2026 earnings call transcriptFebruary 12, 2026 | msn.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 11 at 1:00 AM | Base Camp Trading (Ad)Biotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...February 12, 2026 | finance.yahoo.comBiotricity, Inc. (BTCY) Q3 2026 Earnings Call TranscriptFebruary 11, 2026 | seekingalpha.comBiotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDAFebruary 11, 2026 | globenewswire.comSee More Biotricity Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Biotricity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biotricity and other key companies, straight to your email. Email Address About BiotricityBiotricity (NASDAQ:BTCY) (NASDAQ: BTCY) is a medical technology company focused on remote cardiac monitoring and diagnostic solutions. The company develops connected medical devices and digital health technologies designed to help physicians and healthcare providers monitor patients outside traditional clinical settings. Its product portfolio includes Bioflux, a mobile cardiac telemetry system designed to provide real-time electrocardiogram monitoring and arrhythmia detection, and Biotres, a wearable cardiac monitor intended to support multiple types of ambulatory monitoring. Biotricity also offers Bioheart, a personal cardiac monitoring device designed to help users track heart rate and related cardiac data. Biotricity’s solutions combine wearable hardware, wireless connectivity, data-management software and monitoring services. The company primarily serves healthcare providers, medical practices and patients, with its operations centered in the United States. Biotricity was founded by Waqaas Ahmed, who serves as its chief executive officer.View Biotricity ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles The Trade Desk Beats on Revenue, But the Fine Print MattersWhy Kinder Morgan's Chairman Just Bought $15 Million in StockA $4 Billion Jolt: NRG Energy Powers Data Center AmbitionsD-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?Archer Aviation's FAA Certificate Is a Milestone, But It Isn't the Final OneRocket Lab's Record Backlog Could Fuel a Rebound, But Neutron Raises the StakesDraftKings Just Lost 20%—And Its Biggest Gamble Is Still Ahead Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
